Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19

類似資料

• Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension
  著者:: Li, Gang, 等
  出版事項: (2020)
• SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs
  著者:: Ciulla, Michele M.
  出版事項: (2020)
• Cardiovascular and cerebrovascular outcomes in elderly hypertensive patients treated with either ARB or ACEI
  著者:: Ma, Cong, 等
  出版事項: (2012)
• Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients
  著者:: Bertsimas, Dimitris, 等
  出版事項: (2021)
• Pharmacological rationale for antihypertensive drug choice on COVID‐19–affected patients: ACEI/ARB might not increase their susceptibility
  著者:: Zhao, Hong‐Jin, 等
  出版事項: (2020)